{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:13:33Z","timestamp":1790360013336,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3602000"],"award-info":[{"award-number":["2022YFC3602000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR203330"],"award-info":[{"award-number":["NIHR203330"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015652","name":"Barts Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015652","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"National Institute on Handicapped Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017542","name":"Beijing Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.coi.2026.102785","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:01:12Z","timestamp":1779332472000},"page":"102785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["New learnings from the molecular pathology of the synovial tissue in rheumatoid arthritis: from pathogenesis to therapeutic targeting toward precision medicine"],"prefix":"10.1016","volume":"101","author":[{"given":"Yongjing","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muyun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costantino","family":"Pitzalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2026.102785_bib1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMra2103726","article-title":"Rheumatoid arthritis - common origins, divergent mechanisms","volume":"388","author":"Gravallese","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2026.102785_sbref2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-023-06708-y","article-title":"Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes","volume":"623","author":"Zhang","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.coi.2026.102785_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102785_bib4","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41584-020-0491-4","article-title":"Transforming clinical trials in rheumatology: towards patient-centric precision medicine","volume":"16","author":"Pitzalis","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.coi.2026.102785_bib5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11926-023-01129-2","article-title":"Synovial tissue insights into heterogeneity of rheumatoid arthritis","volume":"26","author":"Jonsson","year":"2024","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.coi.2026.102785_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103581","article-title":"Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts\u2019 consensus","volume":"23","author":"Ruscitti","year":"2024","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.coi.2026.102785_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2174\/1874312901105010100","article-title":"The normal synovium","volume":"5","author":"Smith","year":"2011","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.coi.2026.102785_bib8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri3700","article-title":"Ectopic lymphoid-like structures in infection, cancer and autoimmunity","volume":"14","author":"Pitzalis","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2026.102785_bib9","article-title":"High-grade synovitis associates with clinical markers and response to therapy in chronic inflammatory arthritis: post hoc analysis of a synovial biomarkers prospective cohort study","volume":"14","author":"Garaffoni","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2026.102785_bib10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2559.2006.02508.x","article-title":"Synovitis score: discrimination between chronic low-grade and high-grade synovitis","volume":"49","author":"Krenn","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.coi.2026.102785_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jbspin.2018.04.004","article-title":"IMSYC immunologic synovitis score: a new score for synovial membrane characterization in inflammatory and non-inflammatory arthritis","volume":"86","author":"Najm","year":"2019","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.coi.2026.102785_bib12","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.41726","article-title":"Inclusion of synovial tissue-derived characteristics in a nomogram for the prediction of treatment response in treatment-naive rheumatoid arthritis patients","volume":"73","author":"Alivernini","year":"2021","journal-title":"Arthritis Rheumbatol Hoboken NJ"},{"key":"10.1016\/j.coi.2026.102785_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/BOR.0b013e32835fd8eb","article-title":"New learnings on the pathophysiology of RA from synovial biopsies","volume":"25","author":"Pitzalis","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.coi.2026.102785_bib14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/annrheumdis-2018-214539","article-title":"Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients","volume":"78","author":"Humby","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102785_bib15","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.celrep.2019.07.091","article-title":"Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes","volume":"28","author":"Lewis","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2026.102785_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/ar4555","article-title":"Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics","volume":"16","author":"Dennis","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.coi.2026.102785_bib17","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1136\/annrheumdis-2019-215751","volume":"78","author":"Lliso-Ribera","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102785_bib18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/art.42726","article-title":"Associations between rheumatoid arthritis clinical factors and synovial cell types and states","volume":"76","author":"Weisenfeld","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102785_sbref19","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.immuni.2024.11.004","article-title":"Synovial tissue myeloid dendritic cell subsets exhibit distinct tissue-niche localization and function in health and rheumatoid arthritis","volume":"57","author":"MacDonald","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2026.102785_sbref20","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.ard.2025.07.019","article-title":"Spatial mapping of rheumatoid arthritis synovial niches reveals a LYVE1+ macrophage network associated with response to therapy","volume":"84","author":"De Lima","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102785_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107392","article-title":"Fibroblast-like synoviocytes in rheumatoid arthritis: surface markers and phenotypes","volume":"93","author":"Wu","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.coi.2026.102785_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-02892-y","article-title":"Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis","volume":"9","author":"Mizoguchi","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2026.102785_bib23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","article-title":"Distinct fibroblast subsets drive inflammation and damage in arthritis","volume":"570","author":"Croft","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.coi.2026.102785_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.medj.2022.05.002","article-title":"Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases","volume":"3","author":"Korsunsky","year":"2022","journal-title":"Med"},{"key":"10.1016\/j.coi.2026.102785_sbref25","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/ard-2024-225778","article-title":"ITGA5+ synovial fibroblasts orchestrate proinflammatory niche formation by remodelling the local immune microenvironment in rheumatoid arthritis","volume":"84","author":"Zheng","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102785_sbref26","article-title":"CD142-positive synovial fibroblasts drive meniscus destruction in rheumatoid arthritis","volume":"16","author":"Sun","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2026.102785_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.179392","article-title":"Joint-specific rheumatoid arthritis fibroblast-like synoviocyte regulation identified by integration of chromatin access and transcriptional activity","volume":"9","author":"Choi","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.coi.2026.102785_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk3506","article-title":"Synovial fibroblast gene expression is associated with sensory nerve growth and pain in rheumatoid arthritis","volume":"16","author":"Bai","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2026.102785_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102758","article-title":"Novel insights into macrophage diversity in rheumatoid arthritis synovium","volume":"20","author":"Boutet","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.coi.2026.102785_bib30","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/s41591-020-0939-8","article-title":"Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis","volume":"26","author":"Alivernini","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2026.102785_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102758","article-title":"Novel insights into macrophage diversity in rheumatoid arthritis synovium","volume":"20","author":"Boutet","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.coi.2026.102785_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj1252","article-title":"Loss of synovial tissue macrophage homeostasis precedes rheumatoid arthritis clinical onset","volume":"10","author":"Hanlon","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.coi.2026.102785_bib33","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/ard-2022-223645","article-title":"Immunomics analysis of rheumatoid arthritis identified precursor dendritic cells as a key cell subset of treatment resistance","volume":"82","author":"Yamada","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102785_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ard.2025.05.466","article-title":"Innate immune cell subsets are enriched in synovial fluid of ACPA-negative rheumatoid arthritis and characterized by distinct type I IFN gene signatures","author":"Argyriou","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102785_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-31519-6","article-title":"Single cell sequencing identifies clonally expanded synovial CD4(+) T(PH) cells expressing GPR56 in rheumatoid arthritis","volume":"13","author":"Argyriou","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2026.102785_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-49186-0","article-title":"Clonal associations between lymphocyte subsets and functional states in rheumatoid arthritis synovium","volume":"15","author":"Dunlap","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2026.102785_bib37","article-title":"Single-cell sequencing of immune cells from anticitrullinated peptide antibody positive and negative rheumatoid arthritis","volume":"12","author":"Wu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2026.102785_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1140","article-title":"Synovial fluid CD69(+)CD8(+) T cells with tissue-resident phenotype mediate perforin-dependent citrullination in rheumatoid arthritis","volume":"9","author":"Jung","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.coi.2026.102785_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo0686","article-title":"Granzyme K+ CD8 T cells form a core population in inflamed human tissue","volume":"14","author":"Jonsson","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2026.102785_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-025-08713-9","article-title":"Granzyme K activates the entire complement cascade","volume":"641","author":"Donado","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.coi.2026.102785_bib41","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/ard-2022-222605","article-title":"Age-associated B cells contribute to the pathogenesis of rheumatoid arthritis by inducing activation of fibroblast-like synoviocytes via TNF-\u03b1-mediated ERK1\/2 and JAK-STAT1 pathways","volume":"81","author":"Qin","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102785_bib42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41584-022-00793-5","article-title":"Mechanisms of joint destruction in rheumatoid arthritis \u2014 immune cell\u2013fibroblast\u2013bone interactions","volume":"18","author":"Komatsu","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.coi.2026.102785_bib43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jlb.58.2.209","article-title":"Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation","volume":"58","author":"Yellin","year":"1995","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.coi.2026.102785_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-57361-0","article-title":"Single cell immunoprofile of synovial fluid in rheumatoid arthritis with TNF\/JAK inhibitor treatment","volume":"16","author":"Xia","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2026.102785_bib45","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.immuni.2008.07.018","article-title":"Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction","volume":"29","author":"Ogura","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2026.102785_bib46","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1084\/jem.20071397","article-title":"Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model","volume":"204","author":"Hirota","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2026.102785_bib47","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-017-1353-6","article-title":"Pathogenic roles of CXCL10 signaling through CXCR3 and TLR4 in macrophages and T cells: relevance for arthritis","volume":"19","author":"Lee","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.coi.2026.102785_bib48","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1136\/ard.2011.150219","article-title":"A BAFF\/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells","volume":"70","author":"Bombardieri","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102785_bib49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1172\/JCI11092","article-title":"Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1- and CD106 (VCAM-1)-dependent mechanism","volume":"107","author":"Burger","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2026.102785_sbref50","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/art.43319","article-title":"C3a-C3aR1\u2013mediated interactions between fibroblast-like synoviocytes and macrophages promote the progression of rheumatoid arthritis","volume":"77","author":"Cai","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102785_bib51","doi-asserted-by":"crossref","first-page":"eadr3838","DOI":"10.1126\/sciimmunol.adr3838","article-title":"Human CD4+ T cells regulate peripheral immune responses in rheumatoid arthritis via insulin-like growth factor\u2013like family member 2","volume":"10","author":"Murakami","year":"2025","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coi.2026.102785_bib52","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(20)32341-2","article-title":"Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial","volume":"397","author":"Humby","year":"2021","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.coi.2026.102785_bib53","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41591-022-01789-0","article-title":"Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial","volume":"28","author":"Rivellese","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2026.102785_bib54","doi-asserted-by":"crossref","first-page":"e648","DOI":"10.1016\/S2665-9913(23)00241-2","article-title":"Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials","volume":"5","author":"Rivellese","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.coi.2026.102785_sbref55","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-60987-9","article-title":"Deep molecular profiling of synovial biopsies in the STRAP trial identifies signatures predictive of treatment response to biologic therapies in rheumatoid arthritis","volume":"16","author":"Lewis","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2026.102785_bib56","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-088869","article-title":"Long-term safety and efficacy of anti-GM-CSF otilimab in patients with rheumatoid arthritis: long-term extension of three phase 3 randomised trials (contRAst X)","volume":"15","author":"Weinblatt","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.coi.2026.102785_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1753808","article-title":"Blood-based epigenetic biomarkers in rheumatoid arthritis: current knowledge and future perspectives","volume":"17","author":"Mo\u0142o\u0144","year":"2026","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2026.102785_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr8078","article-title":"Large-scale multicenter study reveals anticitrullinated SR-A peptide antibody as a biomarker and exacerbator for rheumatoid arthritis","volume":"11","author":"Xie","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.coi.2026.102785_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41413-024-00370-4","article-title":"Versatility of 14-3-3 proteins and their roles in bone and joint-related diseases","volume":"12","author":"Zhou","year":"2024","journal-title":"Bone Res"},{"key":"10.1016\/j.coi.2026.102785_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.509","article-title":"Rheumatoid arthritis: pathogenesis and therapeutic advances","volume":"5","author":"Gao","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.coi.2026.102785_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/medicina59091641","article-title":"The use of superb microvascular imaging in evaluating rheumatic diseases: a systematic review","volume":"59","author":"Seskute","year":"2023","journal-title":"Medicina"},{"key":"10.1016\/j.coi.2026.102785_bib62","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.3899\/jrheum.161433","article-title":"The OMERACT rheumatoid arthritis magnetic resonance imaging (MRI) scoring system: updated recommendations by the OMERACT MRI in Arthritis Working Group","volume":"44","author":"\u00d8stergaard","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.coi.2026.102785_bib63","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/art.43194","article-title":"Comparative analysis of circulating and synovial immune cells in early untreated rheumatoid arthritis and their relationship with molecular pathology and disease outcomes","volume":"77","author":"Rivellese","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102785_bib64","doi-asserted-by":"crossref","DOI":"10.1186\/ar4555","article-title":"Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics","volume":"16","author":"Dennis","year":"2014","journal-title":"Arthritis Res Ther"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526000622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526000622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:40:19Z","timestamp":1783932019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791526000622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":64,"alternative-id":["S0952791526000622"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2026.102785","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New learnings from the molecular pathology of the synovial tissue in rheumatoid arthritis: from pathogenesis to therapeutic targeting toward precision medicine","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2026.102785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102785"}}